|
Market Closed -
Nasdaq Helsinki
17:00:00 26/08/2026 BST
|
After hours 19:55:18 | |||
| 80.10 EUR | -0.87% |
|
79.98 | -0.16% |
| 08-10 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
| 08-10 | Orion partner's phase 3 study with levosimendan missed its goals | FW |
Chart: Technical Analysis
Stock exchange
Nasdaq Helsinki
ORNBV 80.10 €
-0.87%
6.65M
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Helsinki
| ORNBV | 80.10EUR | -0.87% | 6.65M € | |
CBOE
| ORNBVh | 80.15EUR | -0.87% | 2.05M € | |
|
Tradegate
| OFK | 80.25EUR | -0.74% | 2.33K € | |
|
London S.E.
| 0M2O | 80.72EUR | -0.19% | 80.72 € | |
|
Deutsche Boerse AG
| OFK | 80.70EUR | +2.02% | 0 € | |
|
CBOE
| 0M2O | 78.80EUR | 0.00% | 0 € | |
|
Börse Stuttgart
| OFK | 79.90EUR | -0.99% | 0 € | |
|
Boerse Muenchen
| OFK | 80.20EUR | -0.74% | 0 € | |
|
Berne S.E.
| OFK | 75.38CHF | +1.81% | 0 CHF | |
|
Borsa Italiana
| 1ORNBV | 80.60EUR | +1.83% | 0 € | |
Nasdaq Helsinki
| ORNAV | 79.80EUR | -0.87% | 261K € | |
|
CBOE
| ORNAVh | 79.90EUR | -0.87% | 59.85K € | |
|
CBOE
| 0M2N | 63.25EUR | 0.00% | 0 € | |
|
Deutsche Boerse AG
| OFKB | 79.50EUR | +1.92% | 0 € | |
Deutsche Boerse AG
| OFK0 | 40.20EUR | +2.03% | 0 € | |
|
OTC Markets
| ORINY | 45.25USD | +5.19% | 27.06K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 82.25 | 82.25 | 81.5 |
| Spread/Res. | -2.61% | -2.61% | -1.72% |
| Spread/Supp. | +6.52% | +11.02% | +18.93% |
| Support | 75.2 | 72.15 | 67.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORNBV Stock
- Charts Orion Oyj
Select your edition
All financial news and data tailored to specific country editions
